IL92294A0 - Alpha-amino-indole-3-acetic acids useful as anti-diabetic,anti-obesity and anti-atherosclerotic agents - Google Patents
Alpha-amino-indole-3-acetic acids useful as anti-diabetic,anti-obesity and anti-atherosclerotic agentsInfo
- Publication number
- IL92294A0 IL92294A0 IL92294A IL9229489A IL92294A0 IL 92294 A0 IL92294 A0 IL 92294A0 IL 92294 A IL92294 A IL 92294A IL 9229489 A IL9229489 A IL 9229489A IL 92294 A0 IL92294 A0 IL 92294A0
- Authority
- IL
- Israel
- Prior art keywords
- indole
- obesity
- diabetic
- alpha
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27055488A | 1988-11-14 | 1988-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL92294A0 true IL92294A0 (en) | 1990-07-26 |
Family
ID=23031777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL92294A IL92294A0 (en) | 1988-11-14 | 1989-11-13 | Alpha-amino-indole-3-acetic acids useful as anti-diabetic,anti-obesity and anti-atherosclerotic agents |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPH04501722A (ko) |
KR (1) | KR920701152A (ko) |
AU (1) | AU4649189A (ko) |
CA (1) | CA2002415A1 (ko) |
IL (1) | IL92294A0 (ko) |
WO (1) | WO1990005721A1 (ko) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571833A (en) * | 1991-06-21 | 1996-11-05 | Smithkline Beecham Plc | Tryptamine analogues, their synthesis and their use as 5-HT1 -like or 5-HT2 receptor agonists |
US5158969A (en) * | 1991-08-21 | 1992-10-27 | Neurosearch A/S | Indole derivatives as potassium channel blockers |
GB9523999D0 (en) | 1995-11-23 | 1996-01-24 | Lilly Co Eli | Indolyl neuropeptide y receptor antagonists |
US6200957B1 (en) | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5849764A (en) * | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5756507A (en) * | 1995-12-14 | 1998-05-26 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5780437A (en) * | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
EA000828B1 (ru) | 1995-12-14 | 2000-04-24 | Мерк Энд Ко., Инк. | Антагонисты гонадотропин-высвобождающего фактора |
EP0948327B1 (en) * | 1996-12-23 | 2006-03-08 | Merck & Co., Inc. | Antidiabetic agents |
US6156772A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6004984A (en) * | 1997-06-05 | 1999-12-21 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5981550A (en) * | 1997-06-05 | 1999-11-09 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6156767A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5985901A (en) * | 1997-06-05 | 1999-11-16 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6159975A (en) * | 1998-02-11 | 2000-12-12 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6025366A (en) * | 1998-04-02 | 2000-02-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6077847A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6110931A (en) * | 1998-04-02 | 2000-08-29 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US6228867B1 (en) | 1998-04-02 | 2001-05-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5998432A (en) * | 1998-04-02 | 1999-12-07 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
US5985892A (en) * | 1998-04-02 | 1999-11-16 | Merck & Co., Ltd. | Antagonists of gonadotropin releasing hormone |
AU3395000A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
EP1171125A1 (en) | 1999-03-10 | 2002-01-16 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
AU3514200A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
IL130169A (en) * | 1999-05-27 | 2006-08-20 | Neurim Pharma 1991 | Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them |
PE20010580A1 (es) * | 1999-09-03 | 2001-05-25 | Takeda Chemical Industries Ltd | Composicion farmaceutica para tratar la diabetes |
EP1305285B1 (en) | 2000-07-25 | 2007-05-16 | Merck & Co., Inc. | N-substituted indoles useful in the treatment of diabetes |
US6620824B2 (en) | 2001-04-11 | 2003-09-16 | Merck & Co., Inc. | Process for the synthesis of gonadotropin releasing hormone antagonists |
WO2005044261A1 (en) * | 2003-10-27 | 2005-05-19 | University Of Iowa Research Foundation | Melatonin analogue prodrugs |
WO2005065050A2 (ja) * | 2003-12-25 | 2005-07-21 | Asahi Kasei Pharma Corporation | 2環化合物 |
US7655691B2 (en) | 2004-09-27 | 2010-02-02 | Sard Howard P | Indole compounds useful as serotonin selective agents |
KR100807718B1 (ko) * | 2006-10-17 | 2008-02-28 | 한국생명공학연구원 | 인돌 유도체를 유효성분으로 함유하는 대사성 질환 예방 및치료용 약학적 조성물 |
DE102008030206A1 (de) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung |
DE102008030207A1 (de) | 2008-06-25 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung |
EP2464227A4 (en) | 2009-08-10 | 2013-02-20 | Galenea Corp | COMPOUNDS AND METHODS OF USE |
GB201411239D0 (en) * | 2014-06-25 | 2014-08-06 | Takeda Pharmaceutical | Novel compounds |
CN114601825B (zh) * | 2022-02-18 | 2023-08-04 | 复旦大学附属中山医院 | 一种肠道菌群代谢物吲哚-3-甲醛在防治动脉粥样硬化中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2542869A (en) * | 1948-03-19 | 1951-02-20 | Merck & Co Inc | N-pyridoxyl-amino acids and process of preparing the same |
US3074942A (en) * | 1958-01-13 | 1963-01-22 | Geigy Chem Corp | alpha-substituted glycine derivatives |
NL125657C (ko) * | 1963-11-26 | |||
GB1080470A (en) * | 1963-12-31 | 1967-08-23 | Merck & Co Inc | Indole derivatives |
EP0031653A1 (en) * | 1979-12-19 | 1981-07-08 | Beecham Group Plc | N-Substituted alpha-amino acids, processes for making them and pharmaceutical compositions containing them |
LU85035A1 (fr) * | 1983-10-07 | 1985-06-19 | Midit | Derives d'amides d'acides amines,leurs preparation et utilisation ainsi que les compositions contenant ces derives |
-
1989
- 1989-10-27 WO PCT/US1989/004711 patent/WO1990005721A1/en unknown
- 1989-10-27 KR KR1019900701508A patent/KR920701152A/ko not_active Application Discontinuation
- 1989-10-27 AU AU46491/89A patent/AU4649189A/en not_active Abandoned
- 1989-10-27 JP JP2500318A patent/JPH04501722A/ja active Pending
- 1989-11-07 CA CA002002415A patent/CA2002415A1/en not_active Abandoned
- 1989-11-13 IL IL92294A patent/IL92294A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2002415A1 (en) | 1990-05-14 |
KR920701152A (ko) | 1992-08-11 |
JPH04501722A (ja) | 1992-03-26 |
WO1990005721A1 (en) | 1990-05-31 |
AU4649189A (en) | 1990-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL92294A0 (en) | Alpha-amino-indole-3-acetic acids useful as anti-diabetic,anti-obesity and anti-atherosclerotic agents | |
HK1009646A1 (en) | Phthalimidohexanperacid process for preparing the same and use thereof | |
IL84653A0 (en) | Carboxybutenoic acids and processes for the preparation thereof | |
EP0413709A4 (en) | Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof | |
EP0328811A3 (en) | Improved return mailer assembly and related process | |
GB8923820D0 (en) | Compound,composition,process and use | |
AU8876591A (en) | Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents | |
EG19278A (en) | Substituted glutaramic acids and derivatives. | |
OA09233A (en) | Permanent waving process and compositions. | |
GB8906102D0 (en) | Soldering material | |
GR890100860A (en) | Composition based on trimebutyne and preparation process | |
GB8817161D0 (en) | Modified proteins | |
IL92033A0 (en) | Catalyst and method for the preparation thereof | |
IL90833A0 (en) | Immunogenic peptide | |
GB8806264D0 (en) | Clip | |
EP0376801A3 (en) | Polyfluoroalkyl-substituted acetates, thioacetates and acetamides, their preparation and uses | |
ZA902826B (en) | Protected amino acids and process for the preparation thereof | |
CS161588A1 (en) | 9-amino-5-fluor-3-oxo-3h-pyrido/3,2,1-yl/phenoxazin-2-carboxylic acids | |
CS16888A1 (en) | Self-sticking flat material | |
IE883396L (en) | Alkanediphosphonic acids | |
GB8803321D0 (en) | Ankenoic acids | |
IE882573L (en) | 4-oxo-3-quinolinecarboxylic acids | |
DE3991138D2 (en) | Neigungskompensator fuer schnellfahrende fahrzeuge, isbesondere schienenfahrzeuge | |
IE881809L (en) | Amino acid 1, 2- diketo derivatives | |
GB8823530D0 (en) | Improved bonding process |